TrialParasites & vectors2018

A multicentre, randomised, non-inferiority clinical trial comparing a nifurtimox-eflornithine combination to standard eflornithine monotherapy for late stage Trypanosoma brucei gambiense human African trypanosomiasis in Uganda.

Freddie Kansiime et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.